ecg analysis software labchart 8.0 Search Results


90
ADInstruments ecg analysis software labchart 8.0
Ecg Analysis Software Labchart 8.0, supplied by ADInstruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecg analysis software labchart 8.0/product/ADInstruments
Average 90 stars, based on 1 article reviews
ecg analysis software labchart 8.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ADInstruments labchart 8.0
Labchart 8.0, supplied by ADInstruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/labchart 8.0/product/ADInstruments
Average 90 stars, based on 1 article reviews
labchart 8.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ADInstruments three-lead electrocardiograph
Three Lead Electrocardiograph, supplied by ADInstruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/three-lead electrocardiograph/product/ADInstruments
Average 90 stars, based on 1 article reviews
three-lead electrocardiograph - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
ADInstruments ecg analysis
Ecg Analysis, supplied by ADInstruments, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecg analysis/product/ADInstruments
Average 96 stars, based on 1 article reviews
ecg analysis - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

90
POWERLAB INC labchart 8.0
Labchart 8.0, supplied by POWERLAB INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/labchart 8.0/product/POWERLAB INC
Average 90 stars, based on 1 article reviews
labchart 8.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ADInstruments labchart
a Cardiac 17-segment model illustrating 25 Gy targeted (Segment 1, red) and remote nontargeted (Segment 10, gray) myocardium collected from a heart failure patient with nonischemic cardiomyopathy and VT (Patient F), who previously received cardiac RT. The nontargeted Segment 10 received <5 Gy radiation exposure. For comparison, corresponding Segments 1 and 10 were collected from 2 nonfailing, non-RT donor hearts rejected for transplantation. b Western blot and quantified densitometry of Na V 1.5 in Segment 10 versus Segment 1 of nonfailing (Donors A and B) and RT-treated (HF+Cardiac RT, red) hearts. c Western blot and quantified densitometry of Cx43 in Segment 10 versus Segment 1 of nonfailing and RT-treated hearts. d Matched QRS durations in the ENCORE-VT patient cohort at baseline (pre-RT, 149 ± 34 ms) versus 6-week post-RT (139 ± 32 ms) timepoints ( n = 19 paired individual patients, P = 0.072 by two-tailed Wilcoxon signed-rank test). e Representative 12-lead <t>ECG</t> of robust QRS shortening recorded from Patient G at the time of RT treatment, with a baseline QRS of 165 ms and presence of LBBB, and then after 6 months post-RT, exhibiting shortened QRS (130 ms) and resolution of LBBB. Examples of pre- and post-RT ECGs of the remaining three patients that exhibited robust QRS shortening in the ENCORE-VT patient cohort, as well as an example of an unchanged QRS interval, are provided in the Supplementary Figures. Source data are provided as a Source data file.
Labchart, supplied by ADInstruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/labchart/product/ADInstruments
Average 90 stars, based on 1 article reviews
labchart - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
POWERLAB INC ecg
a Cardiac 17-segment model illustrating 25 Gy targeted (Segment 1, red) and remote nontargeted (Segment 10, gray) myocardium collected from a heart failure patient with nonischemic cardiomyopathy and VT (Patient F), who previously received cardiac RT. The nontargeted Segment 10 received <5 Gy radiation exposure. For comparison, corresponding Segments 1 and 10 were collected from 2 nonfailing, non-RT donor hearts rejected for transplantation. b Western blot and quantified densitometry of Na V 1.5 in Segment 10 versus Segment 1 of nonfailing (Donors A and B) and RT-treated (HF+Cardiac RT, red) hearts. c Western blot and quantified densitometry of Cx43 in Segment 10 versus Segment 1 of nonfailing and RT-treated hearts. d Matched QRS durations in the ENCORE-VT patient cohort at baseline (pre-RT, 149 ± 34 ms) versus 6-week post-RT (139 ± 32 ms) timepoints ( n = 19 paired individual patients, P = 0.072 by two-tailed Wilcoxon signed-rank test). e Representative 12-lead <t>ECG</t> of robust QRS shortening recorded from Patient G at the time of RT treatment, with a baseline QRS of 165 ms and presence of LBBB, and then after 6 months post-RT, exhibiting shortened QRS (130 ms) and resolution of LBBB. Examples of pre- and post-RT ECGs of the remaining three patients that exhibited robust QRS shortening in the ENCORE-VT patient cohort, as well as an example of an unchanged QRS interval, are provided in the Supplementary Figures. Source data are provided as a Source data file.
Ecg, supplied by POWERLAB INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecg/product/POWERLAB INC
Average 90 stars, based on 1 article reviews
ecg - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ADInstruments hrv labchart pro 8.0
a Cardiac 17-segment model illustrating 25 Gy targeted (Segment 1, red) and remote nontargeted (Segment 10, gray) myocardium collected from a heart failure patient with nonischemic cardiomyopathy and VT (Patient F), who previously received cardiac RT. The nontargeted Segment 10 received <5 Gy radiation exposure. For comparison, corresponding Segments 1 and 10 were collected from 2 nonfailing, non-RT donor hearts rejected for transplantation. b Western blot and quantified densitometry of Na V 1.5 in Segment 10 versus Segment 1 of nonfailing (Donors A and B) and RT-treated (HF+Cardiac RT, red) hearts. c Western blot and quantified densitometry of Cx43 in Segment 10 versus Segment 1 of nonfailing and RT-treated hearts. d Matched QRS durations in the ENCORE-VT patient cohort at baseline (pre-RT, 149 ± 34 ms) versus 6-week post-RT (139 ± 32 ms) timepoints ( n = 19 paired individual patients, P = 0.072 by two-tailed Wilcoxon signed-rank test). e Representative 12-lead <t>ECG</t> of robust QRS shortening recorded from Patient G at the time of RT treatment, with a baseline QRS of 165 ms and presence of LBBB, and then after 6 months post-RT, exhibiting shortened QRS (130 ms) and resolution of LBBB. Examples of pre- and post-RT ECGs of the remaining three patients that exhibited robust QRS shortening in the ENCORE-VT patient cohort, as well as an example of an unchanged QRS interval, are provided in the Supplementary Figures. Source data are provided as a Source data file.
Hrv Labchart Pro 8.0, supplied by ADInstruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hrv labchart pro 8.0/product/ADInstruments
Average 90 stars, based on 1 article reviews
hrv labchart pro 8.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
POWERLAB INC cerebral tissue oxygen
a Cardiac 17-segment model illustrating 25 Gy targeted (Segment 1, red) and remote nontargeted (Segment 10, gray) myocardium collected from a heart failure patient with nonischemic cardiomyopathy and VT (Patient F), who previously received cardiac RT. The nontargeted Segment 10 received <5 Gy radiation exposure. For comparison, corresponding Segments 1 and 10 were collected from 2 nonfailing, non-RT donor hearts rejected for transplantation. b Western blot and quantified densitometry of Na V 1.5 in Segment 10 versus Segment 1 of nonfailing (Donors A and B) and RT-treated (HF+Cardiac RT, red) hearts. c Western blot and quantified densitometry of Cx43 in Segment 10 versus Segment 1 of nonfailing and RT-treated hearts. d Matched QRS durations in the ENCORE-VT patient cohort at baseline (pre-RT, 149 ± 34 ms) versus 6-week post-RT (139 ± 32 ms) timepoints ( n = 19 paired individual patients, P = 0.072 by two-tailed Wilcoxon signed-rank test). e Representative 12-lead <t>ECG</t> of robust QRS shortening recorded from Patient G at the time of RT treatment, with a baseline QRS of 165 ms and presence of LBBB, and then after 6 months post-RT, exhibiting shortened QRS (130 ms) and resolution of LBBB. Examples of pre- and post-RT ECGs of the remaining three patients that exhibited robust QRS shortening in the ENCORE-VT patient cohort, as well as an example of an unchanged QRS interval, are provided in the Supplementary Figures. Source data are provided as a Source data file.
Cerebral Tissue Oxygen, supplied by POWERLAB INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cerebral tissue oxygen/product/POWERLAB INC
Average 90 stars, based on 1 article reviews
cerebral tissue oxygen - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ADInstruments ecg and plethysmograph signals
Example reading of LabChart file . We simultaneously recorded the <t>ECG</t> (bottom) along with plethysmographs from big toe (first from the top), finger (second from the top), and ear (third from the top) and for 30 s each in standing, sitting, and supine positions. The PAT to each location (ear lobe, index finger, and big toe) was assessed by calculating the time delay between the peak of the R wave on the ECG and the first subsequent positive inflection on the plethysmograph trace. Periods consisting of 10 consecutive heart beats from each position (standing, sitting, supine) before and after exercise were then used to calculated the mean PAT for the three locations (ear lobe, index finger, big toe). ECG, <t>electrocardiogram;</t> PAT, pulse arrival time.
Ecg And Plethysmograph Signals, supplied by ADInstruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecg and plethysmograph signals/product/ADInstruments
Average 90 stars, based on 1 article reviews
ecg and plethysmograph signals - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
POWERLAB INC cerebral blood flow
Example reading of LabChart file . We simultaneously recorded the <t>ECG</t> (bottom) along with plethysmographs from big toe (first from the top), finger (second from the top), and ear (third from the top) and for 30 s each in standing, sitting, and supine positions. The PAT to each location (ear lobe, index finger, and big toe) was assessed by calculating the time delay between the peak of the R wave on the ECG and the first subsequent positive inflection on the plethysmograph trace. Periods consisting of 10 consecutive heart beats from each position (standing, sitting, supine) before and after exercise were then used to calculated the mean PAT for the three locations (ear lobe, index finger, big toe). ECG, <t>electrocardiogram;</t> PAT, pulse arrival time.
Cerebral Blood Flow, supplied by POWERLAB INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cerebral blood flow/product/POWERLAB INC
Average 90 stars, based on 1 article reviews
cerebral blood flow - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Covidien surface electrodes kendall 133 foam electrodes
Example reading of LabChart file . We simultaneously recorded the <t>ECG</t> (bottom) along with plethysmographs from big toe (first from the top), finger (second from the top), and ear (third from the top) and for 30 s each in standing, sitting, and supine positions. The PAT to each location (ear lobe, index finger, and big toe) was assessed by calculating the time delay between the peak of the R wave on the ECG and the first subsequent positive inflection on the plethysmograph trace. Periods consisting of 10 consecutive heart beats from each position (standing, sitting, supine) before and after exercise were then used to calculated the mean PAT for the three locations (ear lobe, index finger, big toe). ECG, <t>electrocardiogram;</t> PAT, pulse arrival time.
Surface Electrodes Kendall 133 Foam Electrodes, supplied by Covidien, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/surface electrodes kendall 133 foam electrodes/product/Covidien
Average 90 stars, based on 1 article reviews
surface electrodes kendall 133 foam electrodes - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


a Cardiac 17-segment model illustrating 25 Gy targeted (Segment 1, red) and remote nontargeted (Segment 10, gray) myocardium collected from a heart failure patient with nonischemic cardiomyopathy and VT (Patient F), who previously received cardiac RT. The nontargeted Segment 10 received <5 Gy radiation exposure. For comparison, corresponding Segments 1 and 10 were collected from 2 nonfailing, non-RT donor hearts rejected for transplantation. b Western blot and quantified densitometry of Na V 1.5 in Segment 10 versus Segment 1 of nonfailing (Donors A and B) and RT-treated (HF+Cardiac RT, red) hearts. c Western blot and quantified densitometry of Cx43 in Segment 10 versus Segment 1 of nonfailing and RT-treated hearts. d Matched QRS durations in the ENCORE-VT patient cohort at baseline (pre-RT, 149 ± 34 ms) versus 6-week post-RT (139 ± 32 ms) timepoints ( n = 19 paired individual patients, P = 0.072 by two-tailed Wilcoxon signed-rank test). e Representative 12-lead ECG of robust QRS shortening recorded from Patient G at the time of RT treatment, with a baseline QRS of 165 ms and presence of LBBB, and then after 6 months post-RT, exhibiting shortened QRS (130 ms) and resolution of LBBB. Examples of pre- and post-RT ECGs of the remaining three patients that exhibited robust QRS shortening in the ENCORE-VT patient cohort, as well as an example of an unchanged QRS interval, are provided in the Supplementary Figures. Source data are provided as a Source data file.

Journal: Nature Communications

Article Title: Cardiac radiotherapy induces electrical conduction reprogramming in the absence of transmural fibrosis

doi: 10.1038/s41467-021-25730-0

Figure Lengend Snippet: a Cardiac 17-segment model illustrating 25 Gy targeted (Segment 1, red) and remote nontargeted (Segment 10, gray) myocardium collected from a heart failure patient with nonischemic cardiomyopathy and VT (Patient F), who previously received cardiac RT. The nontargeted Segment 10 received <5 Gy radiation exposure. For comparison, corresponding Segments 1 and 10 were collected from 2 nonfailing, non-RT donor hearts rejected for transplantation. b Western blot and quantified densitometry of Na V 1.5 in Segment 10 versus Segment 1 of nonfailing (Donors A and B) and RT-treated (HF+Cardiac RT, red) hearts. c Western blot and quantified densitometry of Cx43 in Segment 10 versus Segment 1 of nonfailing and RT-treated hearts. d Matched QRS durations in the ENCORE-VT patient cohort at baseline (pre-RT, 149 ± 34 ms) versus 6-week post-RT (139 ± 32 ms) timepoints ( n = 19 paired individual patients, P = 0.072 by two-tailed Wilcoxon signed-rank test). e Representative 12-lead ECG of robust QRS shortening recorded from Patient G at the time of RT treatment, with a baseline QRS of 165 ms and presence of LBBB, and then after 6 months post-RT, exhibiting shortened QRS (130 ms) and resolution of LBBB. Examples of pre- and post-RT ECGs of the remaining three patients that exhibited robust QRS shortening in the ENCORE-VT patient cohort, as well as an example of an unchanged QRS interval, are provided in the Supplementary Figures. Source data are provided as a Source data file.

Article Snippet: Lead II ECGs were recorded at a sampling rate of 4 kHz using LabChart (Version 8.0, ADInstruments), and ECG intervals of 100 averaged beats were measured using the LabChart ECG software package .

Techniques: Comparison, Transplantation Assay, Western Blot, Two Tailed Test

Example reading of LabChart file . We simultaneously recorded the ECG (bottom) along with plethysmographs from big toe (first from the top), finger (second from the top), and ear (third from the top) and for 30 s each in standing, sitting, and supine positions. The PAT to each location (ear lobe, index finger, and big toe) was assessed by calculating the time delay between the peak of the R wave on the ECG and the first subsequent positive inflection on the plethysmograph trace. Periods consisting of 10 consecutive heart beats from each position (standing, sitting, supine) before and after exercise were then used to calculated the mean PAT for the three locations (ear lobe, index finger, big toe). ECG, electrocardiogram; PAT, pulse arrival time.

Journal: Frontiers in Physiology

Article Title: Noninvasive Assessment of the Effect of Position and Exercise on Pulse Arrival to Peripheral Vascular Beds in Healthy Volunteers

doi: 10.3389/fphys.2017.00047

Figure Lengend Snippet: Example reading of LabChart file . We simultaneously recorded the ECG (bottom) along with plethysmographs from big toe (first from the top), finger (second from the top), and ear (third from the top) and for 30 s each in standing, sitting, and supine positions. The PAT to each location (ear lobe, index finger, and big toe) was assessed by calculating the time delay between the peak of the R wave on the ECG and the first subsequent positive inflection on the plethysmograph trace. Periods consisting of 10 consecutive heart beats from each position (standing, sitting, supine) before and after exercise were then used to calculated the mean PAT for the three locations (ear lobe, index finger, big toe). ECG, electrocardiogram; PAT, pulse arrival time.

Article Snippet: The ECG and plethysmograph signals were simultaneously digitally converted at 1 kHz (PowerLab 4/26, ADInsruments, Australia) and analyzed by eye and hand (LabChart 8.0, ADInstruments, Australia).

Techniques: